202 related articles for article (PubMed ID: 10446880)
1. Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes.
Chevrel G; Berger F; Miossec P; Blanc M; Jeanneret J; Felman C; Tebib J
Arthritis Rheum; 1999 Aug; 42(8):1773-6. PubMed ID: 10446880
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
[TBL] [Abstract][Full Text] [Related]
3. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate.
Padeh S; Sharon N; Schiby G; Rechavi G; Passwell JH
J Rheumatol; 1997 Oct; 24(10):2035-7. PubMed ID: 9330950
[TBL] [Abstract][Full Text] [Related]
5. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review.
Kingsmore SF; Hall BD; Allen NB; Rice JR; Caldwell DS
J Rheumatol; 1992 Sep; 19(9):1462-5. PubMed ID: 1433017
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Vincent S; Slease RB; Rocca PV
Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
Usman AR; Yunus MB
J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis.
Thomason RW; Craig FE; Banks PM; Sears DL; Myerson GE; Gulley ML
Mod Pathol; 1996 Mar; 9(3):261-6. PubMed ID: 8685225
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
12. [Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate].
van Poppel PC; Fijnheer R; Haverman JF; Sinniqe HA
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2351-6. PubMed ID: 19024068
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
Clarke LE; Junkins-Hopkins J; Seykora JT; Adler DJ; Elenitsas R
J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
[TBL] [Abstract][Full Text] [Related]
14. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S
Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074
[TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate.
Sibilia J; Lioté F; Mariette X
Rev Rhum Engl Ed; 1998 Apr; 65(4):267-73. PubMed ID: 9599795
[TBL] [Abstract][Full Text] [Related]
16. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
Kojima M; Motoori T; Nakamura S
Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
18. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE.
Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y
J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W
Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
